Global Ganja Report

CBD products are now everywhere—health-food emporia, pharmacies, truck-stops. And pursuant to the 2018 Farm Bill, they are now legal—as long as the CBD is derived from “hemp” as opposed to what has traditionally been called “marijuana.” Hemp, as legally defined, is cannabis with under 0.3% THC—the psychoactive component of the plant, responsible for the long-stigmatized “high.”

But even the hempiest hemp—rope, not dope, as they used to say—usually has some THC.

The son of late reggae legend Peter Tosh, himself a successful musical artist who recorded under the stage name Tosh 1, has died at the age of 40. He'd never fully recovered from a brutal 2017 beating in a New Jersey jail, where he was serving time on a cannabis charge.

The autumn of 2019 saw the United States' first hemp harvest since effective prohibition of the crop under the strictures of the Marihuana Tax Act in 1937. These strictures were overturned in the Farm Bill signed into law by President Trump in the closing days of 2018. This harvest was looked to eagerly across much of rural America, as legal hemp had been plugged as a salvation for the nation's struggling farmers—and the soaring popularity of CBD appeared to provide a booming market. The fashionable cannabinoid had also been legalized by the 2018 Farm Bill—when derived from hemp, or cannabis with less than 0.3% THC.

Hemp’s Curious Cultural Trajectory

Now that hemp has finally arrived at its long-sought status as a legal crop and commodity, there is a sense of inevitability to its deviation from the utopian vision that animated the advocates who fought for it a generation ago.

A tension that has always existed between two currents in the subculture of hemp advocacy is increasingly weighted toward the more mundane—activists versus entrepreneurs, idealism versus pragmatism, agrarianism versus agribusiness. And finally the original paradigm of a crop with multitudinous uses as “food, fuel and fiber,” holding the potential to solve humanity’s ecological crisis, versus the hegemony of CBD.

Thailand’s medical marijuana program, after a slow and cautious start, is about to embark on commercial cultivation following cabinet approval of a proposal from the Health Ministry. Unique among such programs worldwide, the Thai framework is crafted to balance the interests of the pharmaceutical industry and the country's traditional herbal medicine practitioners.

Louisiana's medical marijuana program has been stalled for years, and was strictly limited to begin with. Now, just as cannabis products are finally becoming available, a wave of progressive legislation in the Pelican State includes measures that could expand the program's scope.

Nancy Pelosi roused the ire of Mitch McConnell and anti-pot lobbyists when she defended inclusion of a measure to protect cannabis businesses in the House pandemic recovery bill. Does the science actually point to a therapeutic role for cannabis in treatment of COVID-19?

A new amendment to the Defense Department budget could allow service members to use CBD products—a direct response to a move by Pentagon brass to explicitly restrict all cannabis derivatives.